Bayer EBITDA 2010-2024 | BAYRY

Bayer EBITDA for the quarter ending December 31, 2024 was $3.588B, a 25.37% increase year-over-year.

  • Bayer 2024 EBITDA was 9.427B, a 18.07% decline from 2023.
  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.
  • Bayer 2022 EBITDA was 14.239B, a 87.79% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.

Bayer EBITDA 2010-2024 | BAYRY

  • Bayer 2024 EBITDA was 9.427B, a 18.07% decline from 2023.
  • Bayer 2023 EBITDA was 11.507B, a 19.19% decline from 2022.
  • Bayer 2022 EBITDA was 14.239B, a 87.79% increase from 2021.

EBITDA can be defined as earnings before interest, taxes, depreciation and amortization.
Related Stocks
Company NameMarket
Cap
Eli Lilly (LLY)$823.1B
Johnson & Johnson (JNJ)$380.1B
Novo Nordisk (NVO)$374.3B
AbbVie (ABBV)$348.4B
Roche Holding AG (RHHBY)$259.5B
Novartis AG (NVS)$218.5B
Merck (MRK)$216.5B
Pfizer (PFE)$146.7B
Sanofi (SNY)$136B
Innoviva (INVA)$1.1B